Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1026
Mechanics Bancorp
MCHB
$3.16B
| $13.9M | 0.01% |
565,100
-2,600
| -0.5% | -$60.4K |
2019 Q1
5 quarters
|
|
1027
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $13.9M | 0.01% |
3,060,250
-2,093,250
| -41% | -$9.26M |
2018 Q3
7 quarters
|
|
1028
DELISTED
DURECT Corp
DRRX
| $13.9M | 0.01% |
598,970
+78,149
| +15% | +$1.72M |
2017 Q2
12 quarters
|
|
1029
West Pharmaceutical
WST
$25.8B
| $13.9M | 0.01% |
61,100
-304,100
| -83% | -$59.8M |
2017 Q1
13 quarters
|
|
1030
Hilltop Holdings
HTH
$2.08B
| $13.9M | 0.01% |
751,000
-200,384
| -21% | -$3.44M |
2018 Q3
7 quarters
|
|
|
MNTA
1031
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $13.8M | 0.01% |
416,251
+359,237
| +630% | +$11.4M |
2014 Q1
25 quarters
|
|
1032
NiSource
NI
$19.5B
| $13.8M | 0.01% |
607,300
-1,234,631
| -67% | -$29.8M |
2016 Q3
15 quarters
|
|
1033
AptarGroup
ATR
$7.65B
| $13.8M | 0.01% |
123,300
+95,200
| +339% | +$10.1M |
2020 Q1
1 quarter
|
|
|
ZIXI
1034
DELISTED
Zix Corporation
ZIXI
| $13.8M | 0.01% |
1,999,094
-509,100
| -20% | -$3.08M |
2013 Q2
28 quarters
|
|
1035
DELISTED
Everi Holdings
EVRI
| $13.7M | 0.01% |
2,662,500
-274,600
| -9% | -$1.39M |
2013 Q2
28 quarters
|
|
1036
SunCoke Energy
SXC
$844M
| $13.7M | 0.01% |
4,640,433
-600,318
| -11% | -$1.92M |
2014 Q4
22 quarters
|
|
1037
Oil-Dri
ODC
$1.24B
| $13.7M | 0.01% |
791,492
+31,800
| +4% | +$551K |
2013 Q2
28 quarters
|
|
1038
Landstar System
LSTR
$5.74B
| $13.7M | 0.01% |
122,240
+37,700
| +45% | +$4.03M |
2019 Q4
2 quarters
|
|
|
MIME
1039
DELISTED
Mimecast Limited
MIME
| $13.7M | 0.01% |
329,400
+291,200
| +762% | +$11.4M |
2016 Q3
15 quarters
|
|
|
UBA
1040
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $13.7M | 0.01% |
1,155,022
-266,900
| -19% | -$3.43M |
2013 Q2
28 quarters
|
|
1041
Lite Strategy Inc
LITS
$38.6M
| $13.7M | 0.01% |
165,624
+12,515
| +8% | +$759K |
2015 Q3
19 quarters
|
|
|
CNBKA
1042
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $13.6M | 0.01% |
175,603
-4,998
| -3% | -$349K |
2015 Q2
20 quarters
|
|
|
LGF.A
1043
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $13.6M | 0.01% |
1,841,678
-102,100
| -5% | -$756K |
2019 Q1
5 quarters
|
|
1044
Deluxe
DLX
$1.06B
| $13.6M | 0.01% |
578,310
+96,000
| +20% | +$2.41M |
2018 Q3
7 quarters
|
|
1045
TriMas Corp
TRS
$1.37B
| $13.6M | 0.01% |
568,270
-7,200
| -1% | -$165K |
2017 Q1
13 quarters
|
|
1046
Kemper
KMPR
$1.59B
| $13.6M | 0.01% |
187,236
-39,900
| -18% | -$2.67M |
2017 Q4
10 quarters
|
|
1047
Ironwood Pharmaceuticals
IRWD
$631M
| $13.6M | 0.01% |
1,313,853
-184,600
| -12% | -$1.89M |
2019 Q3
3 quarters
|
|
1048
Nathan's Famous
NATH
$417M
| $13.5M | 0.01% |
240,820
-3,500
| -1% | -$199K |
2013 Q2
28 quarters
|
|
1049
DELISTED
Amedisys
AMED
| $13.5M | 0.01% |
68,201
-100,500
| -60% | -$18.7M |
2018 Q2
8 quarters
|
|
1050
Agilysys
AGYS
$2.96B
| $13.5M | 0.01% |
753,552
+92,903
| +14% | +$1.74M |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.